Shiwen Yap

Shiwen is a pragmatic centrist interested in the intersection of technology, business, entrepreneurship, science and public policy.

SGX needs to seek global partnerships to maximise access to capital: Prof Alex Frino, UOW

“SGX should consider more international collaborations as capital markets are becoming more and more global.”

Panasonic partners US early stage VC Scrum Ventures to launch BeeEdge JV

Panasonic will own 49 per cent interest in the JV vehicle, and is considering investing as a limited partner in Scrum Ventures Fund III.

Singapore Exchange among those in race to pick controlling stake in Tel Aviv bourse

The last major global deal the SGX engaged in was the acquisition of the Baltic Exchange in 2016

Australia: NAB Ventures backs BrickX; AgriDigital closes Series A led by Square Peg

National Australia Bank’s venture capital unit, NAB Ventures, is acquiring a stake in real estate investment platform BrickX.

Japan: Mitsui backs apparel firm IndoChino; Chatbook closes seed round

Chatbook has raised seed funding from Salesforce Ventures, East Ventures and YJ Capital. 

Singapore’s GIC forges $291m JV to develop residential properties in Mexico

Singapore’s sovereign fund GIC has partnered CCLA Group to develop and operate purpose-built, for-rent multi-family buildings across Mexico’s largest cities.

APAC Digest: Korea’s Fast Five, Australia’s Emperor and Japan’s CureApp raise funds

Korea’s work-sharing startup Fast Five, Australia’s Emperor and Japan’s CureApp have secured additional growth funding. 

Tokio Marine Capital exits investments in machine parts maker Tonichi Kosan

Tokyo-listed machinery wholesaler Wakita & Co has acquired an 80% stake in Tonichi Kosan.

SGX to see first fintech listing on Catalist board with Ayondo IPO

Singapore-based PE firm Luminor Capital, a majority shareholder in Ayondo, is seeking to conduct a public float at a potential valuation of $105.6 million.

HK’s PacBridge Capital invests $9.46m in Canada’s Contextual Genomics

PacBridge Capital Partners backs a financial investment in Canadian cancer genomics firm Contextual Genomics.